PREvent For Patients
In the United States alone, there are nearly 18 million patients with coronary artery disease (CAD). It is the largest cause of death in the U.S. and Worldwide. FirstMark recognized the essential need to provide CAD patients a solution to predict the risk of near term heart attack, by introducing the ground breaking solution, PREvent. This predictive test provides necessary information to avoid heart attack and ultimately save lives.
FirstMark PREvent distinguishes the top 4 percent of suspected or confirmed, insignificant or significant CAD patients that are at a 5 times greater risk of a near term (2-3 years) heart attack.
The test guides your doctor to prescribe more intense medical and targeted care, and make cost effective clinical decisions according to your personal needs for therapy, compliance and monitoring.